Dr. Reddy’s Laboratories Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

12.50$ +2.1% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

Dr. Reddy’s Laboratories Ltd (RDY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 81,184 million INR. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of INR.

Tick rows to compare them in a chart (up to 4)

Income Statement RDY
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	832	72,148	70,830	76,727	80,162	83,586	85,060	85,452	88,051	87,268	76,331	81,184	332,834
Cost of Revenue	363	29,945	29,347	30,383	32,393	34,534	37,797	36,825	39,911	40,462	42,116	43,421	165,910
Gross Profit	469	42,203	41,483	46,344	47,769	49,052	47,263	48,627	48,140	46,806	34,215	37,763	166,924
Research & Development	66	5,565	6,877	6,193	7,271	6,658	7,258	6,244	6,202	6,149	5,548	5,800	23,699
Selling, General & Administrative	28,858	20,228	20,476	22,691	23,007	24,117	24,055	23,181	26,436	15,885	14,468	26,096	82,885
Total Operating Expenses	293	25,297	26,524	28,419	30,218	30,332	29,616	31,152	30,627	32,568	33,742	34,791	131,728
Operating Income	176	17,267	14,959	17,925	17,551	18,720	17,647	17,475	17,513	14,238	473	2,972	35,196
Interest Expense	353	394	593	598	757	818	656	830	907	952	1,073	1,262	4,195
Pre-Tax Income	231	18,257	16,016	18,821	19,167	18,742	20,054	19,047	18,350	15,429	2,022	5,559	41,360
Income Tax Expense	52	4,468	2,946	4,901	5,752	4,704	4,182	4,951	4,082	3,533	-217	1,185	8,583
Net Income	179	13,789	13,070	13,920	12,553	14,133	15,938	14,178	14,372	12,098	2,235	4,461	33,167
EBITDA	281	21,286	20,322	21,757	23,899	24,279	25,264	24,642	24,308	19,560	8,758	2,972	55,598

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings